DXCM
Dexcom Inc
Price:  
127.37 
USD
Volume:  
2,275,563.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Dexcom EV/EBITDA

-58.1%
Upside

As of 2024-05-25, the EV/EBITDA ratio of Dexcom Inc (DXCM) is 57.82. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Dexcom's latest enterprise value is 52,294.90 mil USD. Dexcom's TTM EBITDA according to its financial statements is 904.50 mil USD. Dividing these 2 quantities gives us the above Dexcom EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 18.1x - 27.4x 24.6x
Forward P/E multiples 20.1x - 22.7x 20.8x
Fair Price 36.95 - 60.29 53.40
Upside -71.0% - -52.7% -58.1%
127.37 USD
Stock Price
53.40 USD
Fair Price

Dexcom EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-24 57.82
2024-05-23 57.04
2024-05-22 59.21
2024-05-21 59.34
2024-05-20 59.28
2024-05-17 59.57
2024-05-16 59.81
2024-05-15 58.85
2024-05-14 57.20
2024-05-13 56.75
2024-05-10 57.68
2024-05-09 58.15
2024-05-08 57.84
2024-05-07 59.02
2024-05-06 58.82
2024-05-03 58.26
2024-05-02 57.50
2024-05-01 57.16
2024-04-30 57.83
2024-04-29 57.13
2024-04-26 56.48
2024-04-25 62.49
2024-04-24 62.43
2024-04-23 60.73
2024-04-22 59.64
2024-04-19 59.28
2024-04-18 60.86
2024-04-17 60.67
2024-04-16 61.84
2024-04-15 60.98
2024-04-12 61.67
2024-04-11 63.20
2024-04-10 63.51
2024-04-09 63.57
2024-04-08 63.34
2024-04-05 62.90
2024-04-04 60.44
2024-04-03 62.71
2024-04-02 61.90
2024-04-01 62.46
2024-03-28 62.80
2024-03-27 63.14
2024-03-26 63.34
2024-03-25 63.41
2024-03-22 60.37
2024-03-21 60.47
2024-03-20 60.09
2024-03-19 60.81
2024-03-18 61.05
2024-03-15 59.17